<DOC>
	<DOCNO>NCT00713700</DOCNO>
	<brief_summary>The objective study investigate safety effectiveness ADO II patient PDA .</brief_summary>
	<brief_title>AMPLATZER Duct Occluder II Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<criteria>Subject must diagnosis PDA Subject must PDA &lt; 5.5mm diameter angiography Subject must PDA &lt; 12mm length angiography Subject must PDA &gt; 3mm length angiography Subject/legally authorize representative must give consent participate clinical study Subject/legally authorize representative must consent followup duration clinical study Subject must &lt; 6 kilogram procedure Subject must &lt; 6 month age Subject must â‰¥ 18 year age Subject must descend aorta &lt; 10mm diameter Subject must right left shunt patent ductus arteriosus Subject must PVR 8 Woods unit Rp/Rs &gt; 0.4 Subject must intracardiac thrombus Subject must additional cardiac anomaly require surgical interventional correction Subject must history two low respiratory infection within last year ( i.e. , pneumonia ) Subject must active infection require treatment time implant Subject must contraindication anticoagulation treatment Female subject child bearing age must pregnant desire become pregnant within six month post implant* Subject must participate another study investigational drug and/or device may clinically interfere study 's endpoint If subject desire become pregnant six month postimplant , restriction discretion physician .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>patent ductus arteriosus</keyword>
	<keyword>PDA</keyword>
</DOC>